Skip to main content
Erschienen in: Breast Cancer Research 4/2003

01.08.2003 | Book report

Expert Group: IARC Handbooks of Cancer Prevention. Vol.7: Breast Cancer Screening. Lyon, France: IARC; 2002. 248pp.

ISBN 92 832 3007 8

verfasst von: Robert A Smith, PhD

Erschienen in: Breast Cancer Research | Ausgabe 4/2003

Einloggen, um Zugang zu erhalten

Excerpt

The latest publication in the International Agency for Research on Cancer's (IARC) series of Handbooks of Cancer Prevention is focused on breast cancer screening. The monograph is the outcome of a weeklong meeting of the Working Group on the Evaluation of Cancer-Preventive Strategies that took place in Lyon, France, March 5–12, 2002. The decision to produce a handbook on breast cancer screening was timely for several reasons. First, only a few monographs exist that focus exclusively on breast cancer screening, none of which represent a comprehensive treatment of the subject, and all were published before 1990 [14]. Second, the value of breast cancer screening recently had been challenged by a Cochrane Review [5] on screening for breast cancer with mammography, and a number of independent expert groups had been assembled to evaluate that analysis and the authors' provocative conclusions. Thus, in the presence of another expert group's conclusion that there was no scientific evidence to support the value of mammography, the IARC Working Group's evaluation of the world's literature on the efficacy of breast cancer screening had an extra dimension of drama. Contrary to the Cochrane Review, the IARC Working Group affirmed the value of mammography for women aged 50–69. …
Literatur
1.
Zurück zum Zitat Forrest P: Breast Cancer: the decision to screen. Oxfordshire, England: Nuffield Provincial Hospitals Trust. 1990 Forrest P: Breast Cancer: the decision to screen. Oxfordshire, England: Nuffield Provincial Hospitals Trust. 1990
2.
Zurück zum Zitat Shapiro S, Venet W, Strax P, Venet L: Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae. Baltimore: Johns Hopkins Press. 1988 Shapiro S, Venet W, Strax P, Venet L: Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae. Baltimore: Johns Hopkins Press. 1988
3.
Zurück zum Zitat Bassett LW, Hendrick RE, Bassford TL, Butler PF, Carter D, DeBor M, D'Orsi CJ, Garlinghouse CJ, Jones RF, Langer AS, Lichtenfeld JL, Osuch JR, Reynolds LN, de Paredes ES, Williams RE: Quality Determinants of Mammography. Clinical Practice Guidelines, No. 13, Publication No. 95-00632. Rockville, MD: AHCPR Agency for Health Care Policy and Research Public Health Service, US Department of Health and Human Services. 1994 Bassett LW, Hendrick RE, Bassford TL, Butler PF, Carter D, DeBor M, D'Orsi CJ, Garlinghouse CJ, Jones RF, Langer AS, Lichtenfeld JL, Osuch JR, Reynolds LN, de Paredes ES, Williams RE: Quality Determinants of Mammography. Clinical Practice Guidelines, No. 13, Publication No. 95-00632. Rockville, MD: AHCPR Agency for Health Care Policy and Research Public Health Service, US Department of Health and Human Services. 1994
4.
Zurück zum Zitat Day NE, Miller AB: Screening for breast cancer;. Toronto: Hans Huber;. 1988 Day NE, Miller AB: Screening for breast cancer;. Toronto: Hans Huber;. 1988
5.
Zurück zum Zitat Olsen O, Gotzsche PC: Screening for breast cancer with mammography (Cochrane Review). Cochrane Database Syst Rev. 2001, 4: CD001877- Olsen O, Gotzsche PC: Screening for breast cancer with mammography (Cochrane Review). Cochrane Database Syst Rev. 2001, 4: CD001877-
6.
Zurück zum Zitat Wilson JMG, Junger G: Principles and practice of screening for disease. Geneva, Switzerland: World Health Organization. 1968 Wilson JMG, Junger G: Principles and practice of screening for disease. Geneva, Switzerland: World Health Organization. 1968
7.
Zurück zum Zitat Organizing Committee and Collaborators, Falun meeting, Falun, Sweden: Breast cancer screening with mammography in women aged 40–49 years. Int J Cancer. 1996, 68: 693-99. 10.1002/(SICI)1097-0215(19961211)68:6<693::AID-IJC1>3.3.CO;2-P.CrossRef Organizing Committee and Collaborators, Falun meeting, Falun, Sweden: Breast cancer screening with mammography in women aged 40–49 years. Int J Cancer. 1996, 68: 693-99. 10.1002/(SICI)1097-0215(19961211)68:6<693::AID-IJC1>3.3.CO;2-P.CrossRef
8.
Zurück zum Zitat Hendrick RE, Smith RA, Rutledge JH, Smart CR: Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr. 1997, 22: 87-92. Hendrick RE, Smith RA, Rutledge JH, Smart CR: Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr. 1997, 22: 87-92.
9.
Zurück zum Zitat Humphrey LL, Helfand M, Chan BK, Woolf SH: Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002, 137: 347-360.CrossRefPubMed Humphrey LL, Helfand M, Chan BK, Woolf SH: Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002, 137: 347-360.CrossRefPubMed
10.
Zurück zum Zitat Tabar L, Vitak B, Tony HH, Yen MF, Duffy SW, Smith RA: Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001, 91: 1724-1731. 10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V.CrossRefPubMed Tabar L, Vitak B, Tony HH, Yen MF, Duffy SW, Smith RA: Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001, 91: 1724-1731. 10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V.CrossRefPubMed
11.
Zurück zum Zitat Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, Bianchi S, del Turco MR: Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990–96. Br J Cancer. 2002, 87: 65-69. 10.1038/sj.bjc.6600301.CrossRefPubMedPubMedCentral Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, Bianchi S, del Turco MR: Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990–96. Br J Cancer. 2002, 87: 65-69. 10.1038/sj.bjc.6600301.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003, 361: 1405-1410. 10.1016/S0140-6736(03)13143-1.CrossRefPubMed Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003, 361: 1405-1410. 10.1016/S0140-6736(03)13143-1.CrossRefPubMed
13.
Zurück zum Zitat Yen MM, Tabár L, Vitak B, Smith R, Chen HH, Duffy SW: Quantifying the potential problem of overdiagnosis of ductal carcinoma in situin breast cancer screening. Eur J Cancer. 2003, Yen MM, Tabár L, Vitak B, Smith R, Chen HH, Duffy SW: Quantifying the potential problem of overdiagnosis of ductal carcinoma in situin breast cancer screening. Eur J Cancer. 2003,
14.
Zurück zum Zitat Paci E, Duffy SW, Giorgi D, Prevost TC, Rosselli del Turco M: Population-based breast cancer screening programmes: estimates of sensitivity, overdiagnosis and early prediction of the benefit. In Quantitative methods for the evaluation of cancer screening. Edited by: Duffy SW, Hill C, Esteve J. 2001, London: Arnold, 127-135. Paci E, Duffy SW, Giorgi D, Prevost TC, Rosselli del Turco M: Population-based breast cancer screening programmes: estimates of sensitivity, overdiagnosis and early prediction of the benefit. In Quantitative methods for the evaluation of cancer screening. Edited by: Duffy SW, Hill C, Esteve J. 2001, London: Arnold, 127-135.
Metadaten
Titel
Expert Group: IARC Handbooks of Cancer Prevention. Vol.7: Breast Cancer Screening. Lyon, France: IARC; 2002. 248pp.
ISBN 92 832 3007 8
verfasst von
Robert A Smith, PhD
Publikationsdatum
01.08.2003
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe 4/2003
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr616

Weitere Artikel der Ausgabe 4/2003

Breast Cancer Research 4/2003 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.